Atropine Sulfate
NDC Package 51662-1378-1

11-digit billing NDC: 51662137801

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Atropine Sulfate is injection, USP, may be given parenterally as a pre-anesthetic medication in surgical patients to reduce salivation and bronchial secretions. Marketed by Hf Acquisition Co Llc, Dba Healthfirst, this product is identified by NDC 51662-1378.

Identification & Billing

NDC Package Code
51662-1378-1
Package Description
1 SYRINGE in 1 BOX / 10 mL in 1 SYRINGE
Product Code
11-Digit Billing Format
51662137801
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Atropine Sulfate
Dosage Form
-
Usage Information
Atropine Sulfate Injection, USP, may be given parenterally as a pre-anesthetic medication in surgical patients to reduce salivation and bronchial secretions. It may also be used to suppress vagal activity associated with the use of halogenated hydrocarbons during inhalation anesthesia and reflex excitation arising from mechanical stimulation during surgery.The antispasmodic action of atropine is useful in pylorospasm and other spastic conditions of the gastrointestinal tract. For ureteral and biliary colic, atropine concomitantly with morphine may be indicated.Atropine relaxes the upper GI tract and colon during hypotonic radiography.In poisoning by the organic phosphate cholinesterase inhibitors found in certain insecticides and by chemical warfare nerve gases, large doses of atropine relieve the muscarine-like symptoms and some of the central nervous system manifestations. It is also used as an antidote for mushroom poisoning due to muscarine in certain species such as Amanita muscaria.

Regulatory & Marketing

Labeler Name
Hf Acquisition Co Llc, Dba Healthfirst
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
10-15-2019
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51662-1378-1 identifies a specific commercial package of 1 syringe in 1 box / 10 ml in 1 syringe of Atropine Sulfate, labeled by Hf Acquisition Co Llc, Dba Healthfirst. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hf Acquisition Co Llc, Dba Healthfirst on October 15, 2019. The current certification is valid through December 31, 2024.

How is this Hf Acquisition Co Llc, Dba Healthfirst product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51662137801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51662-1378-1
11-Digit CMS (5-4-2)
51662-1378-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.